Douglas Swirsky – Biography
Last update: January 21, 2026Executive profile
Douglas was Chairman of the Board at Cellectar Biosciences, and Board Member at MetaVia. Douglas Swirsky joined Cellectar in 2020. Douglas served as Interim President and Interim Chief Financial Officer for Cellectar.
Douglas Swirsky is currentlyChief Financial Officer (until Mar 30 2026) at MaxCyte - View - MaxCyte org chart
Chairman of the Board at Cellectar - View - Cellectar org chart
Create your alert
to follow the career of Douglas Swirsky.
Education
In 1997, Douglas Swirsky completed a Master of Business Administration at Northwestern University - Kellogg School of Management.
They have also studied at Northwestern University - Kellogg School of Management :
Find more alumni from Northwestern University - Kellogg School of Management
More about Douglas Swirsky
Selected links
Do you need to know more about Douglas Swirsky? More results.
Participate
Social media
- Douglas Swirsky on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Douglas Swirsky
The colleagues of Douglas Swirsky
Company Colleagues
- At MaxCyte, Douglas Swirsky has 23 colleagues including Maher Masoud (CEO & President), Patrick Balthrop (Lead Director)…
- At Cellectar, Douglas Swirsky has 10 colleagues including James Caruso (CEO & Director), John Neis (Director)…
Homonyms
- Douglas Swirsky - Chief Financial Officer and Principal Accounting Officer - Barinthus Biotherapeutics
Industry Colleagues
- In the Biotechnology industry, Douglas Swirsky has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Douglas Swirsky.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Douglas Swirsky.
